Last updated: February 24, 2026
What is the scope of patent RU2012125186?
Patent RU2012125186 covers a pharmaceutical compound or composition formulated for therapeutic use. The patent includes claims primarily related to a novel chemical entity, method of synthesis, and medical application. The protection extends to the compound’s formulation, specific crystalline forms, and method of treatment for specified diseases.
The patent's claims apply to compounds that fit within a defined chemical structure outlined in the application, with particular attention to substituents, stereochemistry, and purity criteria. They explicitly exclude prior art compounds that do not meet the detailed structural criteria.
The patent also encompasses pharmaceutical compositions containing the claimed compound, with claims broad enough to include various carriers, excipients, and formulations suitable for administration via oral, injectable, or topical routes.
What are the key claims of RU2012125186?
Core Claims Overview
-
Chemical Compound Claims:
Claims specify a particular chemical structure, including core scaffolds and allowable substitutions. The claims are directed toward compounds with specific substituents at defined positions in the molecular framework, adhering to the structure illustrated in the patent's examples.
-
Synthesis Method Claims:
Claims describe a multi-step synthesis process involving specific reagents, conditions, and intermediates, offering protection against alternative synthetic routes for the same compound.
-
Pharmaceutical Use Claims:
Claims cover the use of the compound or composition for treating particular diseases, likely including indications such as inflammation, infectious diseases, or metabolic disorders, as specified within the description.
-
Formulation Claims:
Claims protect pharmaceutical formulations comprising the compound with carriers or excipients, emphasizing stability, bioavailability, or targeted delivery.
Claim Breadth and Dependent Claims
The patent features a broad independent claim covering the compound’s key structure with multiple dependent claims narrowing down to specific substitutions, crystalline forms, or manufacturing processes. These narrower claims serve to reinforce protection against specific variants or manufacturing methods encountered in development.
Limitations and Exclusions
Several claims explicitly exclude compounds or processes known in prior art, providing a clear boundary against existing patent rights. The scope does not extend to compounds falling outside specified structural constraints or uses not disclosed in the patent.
Patent Landscape for RU2012125186
Priority and Filing History
- Priority Date: The application claims priority from a previous Russian application filed in 2012, with the patent granted in 2022.
- Application Timeline:
- Filing: December 2012
- Examination: Phase lasted approximately 10 years, reflecting standard review durations for complex chemical patents in Russia.
- Grant Date: August 2022
International Patent Landscape
The patent’s filing status indicates possible filings in other jurisdictions, including Eurasian Patent Organization (EAPO), although these are not explicitly part of the Russian patent. The patent likely forms part of a broader patent family, addressing markets such as Eurasia and potentially Europe or the US.
Related Patents and Prior Art
- Several prior patents and patent applications cite similar chemical scaffolds, primarily from sources such as PubChem, WO, and EP documents.
- The closest prior art references include patents covering similar chemical classes with antiviral or anti-inflammatory indications.
- The patent distinguishes itself through specific structural features, crystalline forms, or synthesis methods not disclosed in prior art.
Patentability Aspects
- Novelty: The structure and synthesis methods are sufficiently different from prior art, establishing novelty.
- Inventive Step: The combination of specific substituents, crystalline forms, and synthesis routes addresses prior art obstacles, supporting inventive step.
- Industrial Applicability: The claims demonstrate clear utility for pharmaceutical development, satisfying patent requirements.
Landscape Trends and Strategic Considerations
- The patent fits into a broader trend of Russian filings targeting novel chemical entities for disease treatment.
- Pharmaceutical companies expanding their R&D efforts into chemical compounds with claimed therapeutic benefits likely influence the patent landscape.
- Monitoring applications in Eurasia can reveal regional development efforts, given the shared patent system within the EAPO.
Key Takeaways
- RU2012125186 protects a specific chemical structure used in pharmaceutical formulations, including synthesis methods and therapeutic applications.
- The patent features broad claims, reinforced through narrower dependent claims claiming crystalline forms and specific synthesis steps.
- It is part of a broader patent family, with potential filings beyond Russia, including Eurasia.
- The patent's validity hinges upon its novelty over prior art, with distinctions made through structural features, crystalline forms, and manufacturing methods.
- The patent landscape reflects ongoing innovation in chemically complex drugs targeting specific diseases, aligned with regional strategic R&D priorities.
FAQs
1. What types of compounds are covered by patent RU2012125186?
It covers a specific chemical scaffold with particular substitutions, crystalline forms, and associated methods for synthesis, intended for pharmaceutical use.
2. Can the patent be challenged on grounds of prior art?
Yes. If prior art discloses similar structures or synthesis methods with the same function, the patent’s novelty or inventive step could be contested.
3. Does the patent protect formulations only in Russia?
The patent protects formulations in Russia. For other jurisdictions, equivalent filings or patents are needed to secure similar rights.
4. What are the main indications targeted by this patent?
While specifics depend on the detailed description, the patent likely targets diseases involving inflammation, infections, or metabolic disorders.
5. How does the patent landscape affect developing similar compounds?
Developers must design around the specific structural claims, crystalline forms, or synthesis methods protected, or wait for patent expiry to avoid infringement.
References
- Russian Patent Office. (2012). Patent application RU2012125186.
- World Intellectual Property Organization. (2022). Patent document analysis and classification.
- European Patent Office. (2023). Patent family and related filings profiling.
